Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerance, and pharmacokinetics of Retrovir (AZT) administration in
HIV-infected patients in renal failure receiving maintenance hemodialysis.